Skip to main navigation Skip to search Skip to main content

Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome

  • M. Kulke
  • , D. Hörsch
  • , M. Caplin
  • , L. Anthony
  • , E. Bergsland
  • , K. Oberg
  • , S. Welin
  • , R. Warner
  • , C. Lombard Bohas
  • , P. L. Kunz
  • , E. Grande
  • , J. W. Valle
  • , P. Lapuerta
  • , P. Banks
  • , S. Jackson
  • , W. Jiang
  • , T. Biran
  • , M. Pavel

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)vi138
JournalAnnals of Oncology
Volume27
DOIs
StatePublished - Oct 1 2016

Funding

P.L. Kunz: Grants and personal fees from Lexicon Pharmaceuticals, grants and personal fees from Novartis, outside the submitted work.

Funders
Pfizer

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Fingerprint

    Dive into the research topics of 'Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome'. Together they form a unique fingerprint.

    Cite this